Half-Life of CJC-1295 DAC: How Long It Stays Active

The half-life of CJC-1295 DAC is roughly 6 to 8 days in published research. That long window comes from the drug affinity complex (DAC) attached to the peptide, which lets it bind to albumin and avoid rapid breakdown. By contrast, the same peptide without DAC is cleared in about 30 minutes.

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog studied for its effects on GH and IGF-1. It is not FDA-approved for human use in the United States. This article explains what the half-life means, how it compares with the no-DAC version, and why the difference matters for research dosing.

What Half-Life Means for CJC-1295 DAC

Half-life is the time it takes for half of a dose to be cleared from the body. A longer half-life means the compound stays active for more hours or days. For CJC-1295 DAC, that number is measured in days, not minutes.

Researchers often cite a range because half-life depends on the model, the assay, and the individual. The DAC form is consistently described as long-acting, while the no-DAC form is short-acting. That single difference shapes nearly every dosing protocol discussed online.

Why the DAC Moiety Extends the Half-Life

The DAC part of CJC-1295 reacts with serum albumin after injection. Albumin is a large blood protein that circulates for weeks. When CJC-1295 binds to it, the peptide is protected from enzymes that would otherwise break it down quickly.

This is not a slow-release depot. It is a reversible albumin binding that keeps the peptide in circulation. The result is a much longer half-life and a much flatter GH pulse compared with short-acting GHRH analogs.

• Without DAC: rapid enzyme breakdown, short pulse, half-life around 30 minutes.
• With DAC: albumin binding, prolonged exposure, half-life around 6 to 8 days.

CJC-1295 With DAC vs Without DAC: Half-Life Comparison

The table below summarizes the main pharmacokinetic difference between the two forms. It is based on published research data, not on individual clinical outcomes.

The gap between these numbers is enormous. A single dose of the DAC form can remain measurable for days, while the no-DAC form is largely gone within an hour. That is why researchers sometimes describe cjc 1295 with dac half life as weekly and the no-DAC half-life as meal-time.

How Long Does CJC-1295 DAC Stay in Your System?

If the half-life is about 7 days, it takes roughly five half-lives, or around 35 days, for the compound to be almost fully cleared. Some sources estimate 30 to 40 days for full elimination. This is a rough estimate, not a personal timeline.

Individual factors such as body weight, liver and kidney function, injection site, and frequency of use can change clearance. Age and overall health may also play a role. No study has defined an exact clearance day for every person.

Half-Life of CJC-1295 No DAC and Why It Matters

The half-life of cjc-1295 no dac is only about 30 minutes because there is no albumin-binding group. That short window produces a brief GH pulse similar to the body's natural rhythm. Many research protocols use multiple daily injections to mimic that pattern.

Some people compare the two forms by asking about cjc-1295 no dac half-life versus the DAC version. The short answer: the no-DAC form is designed for pulsatility, and the DAC form is designed for sustained exposure. They answer different research questions.

Dosing and Frequency Implications

Because of the long half-life, CJC-1295 DAC is usually studied with once-weekly or biweekly dosing. The no-DAC form is studied with 2 to 3 daily doses. This difference is a direct consequence of pharmacokinetics, not a matter of preference.

Researchers who want a steady IGF-1 elevation tend to choose the DAC form. Researchers who want to study pulsatile GH release tend to choose the no-DAC form. The cjc 1295 dac half life also means that side effects, if any, may last longer and be harder to reverse quickly.

Factors That Can Affect the Half-Life

Half-life is not a fixed number for every person or every study. Several variables can shift how long CJC-1295 DAC stays active:

• Albumin levels: Low albumin may reduce binding and shorten exposure.
• Injection route: Subcutaneous absorption can vary more than intravenous delivery.
• Metabolism: Liver and kidney function affect peptide clearance.
• Dose size: Higher doses can temporarily saturate clearance pathways.
• Assay sensitivity: Different lab tests detect different amounts of drug.

These factors explain why published half-lives range from about 5.8 to 8.2 days in some reports. The practical takeaway is that the DAC form is long-acting by design, but no single number is universal.

Safety, Legal Status, and Research Use

CJC-1295 DAC is not approved by the FDA for human use in the United States. It is sold as a research chemical, and human use is not recommended. Potential side effects reported in research include injection-site reactions, water retention, and changes in blood sugar or IGF-1 levels.

Anyone considering CJC-1295 should consult a licensed healthcare professional. Self-dosing with unapproved peptides carries legal and health risks. The cjc-1295 with dac half-life of 6 to 8 days also means that any adverse effect could persist for days after a dose.

Bottom Line on the Half-Life of CJC-1295 DAC

The half-life of CJC-1295 DAC is approximately 6 to 8 days. That is roughly 300 times longer than the no-DAC form. The difference comes from albumin binding and is the main reason dosing schedules differ so much between the two peptides.

Research on CJC-1295 is ongoing, and the FDA has not approved it for any human indication. If you have questions about growth hormone peptides, talk to a healthcare provider before making any decisions.